Navigation Links
CFO of China Yingxia Emphasizes Growth in Organic and Health Food Segment in Interview by The Wall Street Transcript

HARBIN, China, Oct. 20 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the health and nutritional food industry engaged in the development, manufacture and distribution of nutritional food products, dietary supplements, and raw cactus plants in the People's Republic of China ("PRC"), today announced that the Company's Chief Financial Officer Ren Hu was interviewed by the Wall Street Transcript to discuss the Company's growth strategy involving its organic and health food business. The interview was published October 20, 2008.

In the interview, Mr. Hu stated that the demand for organic and health food in China is propelled by the increasing disposable income of Chinese urbanites, along with concerns over food safety. China Yingxia has actively focused on growing its nutritional food segment to address this demand. The recent acquisition of a soy milk production facility in Shanghai was a step in this direction, as it equipped the Company with advanced food processing technology for the production of soy milk and soy yogurt.

On addressing the recent scandal involving contaminated cow's milk in China, Mr. Hu considered it to be an opportunity for China Yingxia, since the Company's products are soybean based milk and yogurt, while the majority of the tainted products were derived from cow's milk. The Company's integrated business model and rigid quality control procedures also prevent harmful substances from entering the production process. Soy milk is believed to have more health benefits and a scandal like this may urge more consumers to look for alternatives to cow's milk. China Yingxia will start a marketing campaign to position the Company's organic and health food products attractively to the consumers.

"China Yingxia follows two main strategies to expand its market," Mr. Hu stated in the interview. "The first is to expand the distribution network by adding more stores via proper marketing campaigns and promotions. The second strategy is to grow through acquisitions to break geographical barriers."

About China Yingxia International, Inc.

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ('Yingxia'), is primarily engaged in the development, production and sales of health food products in China. Yingxia is located in the Province of Heilongjiang, Peoples Republic of China. Yingxia's products include soybean-based foods and drinks, longgu golden millet enriched products, organic rice products, raw cacti, cactus and other herbal-based supplements, cosmetics, personal care products, and Nestle products.

Safe Harbor Statement

The statements contained herein that are not historical facts are 'forward-looking statements' within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as 'believes,' 'expects,' 'may,' 'will,' 'should,' or 'anticipates,' 'expect' or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets or forecasting financial results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

For more information, please contact:

Company Contact:

Mr. Ren Hu

Chief Financial Officer

China Yingxia International, Inc.

Tel: +1-201-887-0415


Investor Relations Contact:

Mr. Crocker Coulson


CCG Investor Relations

Tel: +1-646-213-1915



SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Waters Publishes Rapid and Specific Method of Detection for Melamine in Infant Formula and Liquid Milk, in Support of Chinas Ministry of Science and Technology
2. China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million
3. China Bio Energy Holdings Group Announces Financing and Exercise of Warrants
4. China-Biotics, Inc. Retains KPMG for the Implementation of Sarbanes-Oxley Act Section 404
5. China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xian Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009
6. China-Biotics, Inc. Approved to List on the Nasdaq Global Market
7. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
8. China Medicine to Showcase Bethin Weight Loss Product at 2008 Natural Products Expo East Trade Show
9. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
10. China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
11. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
Breaking Biology News(10 mins):